Karolinska Development Financials
| KDEV Stock | SEK 1.03 0.01 0.96% |
Karolinska |
Understanding current and past Karolinska Development Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Karolinska Development's financial statements are interrelated, with each one affecting the others. For example, an increase in Karolinska Development's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Karolinska Development's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Karolinska Development AB. Check Karolinska Development's Beneish M Score to see the likelihood of Karolinska Development's management manipulating its earnings.
Karolinska Development Stock Summary
Karolinska Development competes with Oncopeptides, Cantargia, BioInvent International, Moberg Pharma, and BioArctic. Karolinska Development AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. Karolinska Development AB was founded in 2003 and is headquartered in Stockholm, Sweden. Karolinska Development operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 7 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0002190926 |
| Business Address | Tomtebodavgen 23 A, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.karolinskadevelopment.com |
| Phone | 46 8 52 48 60 70 |
| Currency | SEK - Swedish Kronor |
You should never invest in Karolinska Development without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Karolinska Stock, because this is throwing your money away. Analyzing the key information contained in Karolinska Development's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Karolinska Development Key Financial Ratios
Karolinska Development's financial ratios allow both analysts and investors to convert raw data from Karolinska Development's financial statements into concise, actionable information that can be used to evaluate the performance of Karolinska Development over time and compare it to other companies across industries.| Return On Equity | -0.11 | |||
| Return On Asset | -0.0168 | |||
| Target Price | 4.5 | |||
| Beta | 0.4 | |||
| Z Score | -1.4 |
Karolinska Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Karolinska Development's current stock value. Our valuation model uses many indicators to compare Karolinska Development value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Karolinska Development competition to find correlations between indicators driving Karolinska Development's intrinsic value. More Info.Karolinska Development AB is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Karolinska Development's earnings, one of the primary drivers of an investment's value.Karolinska Development Systematic Risk
Karolinska Development's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Karolinska Development volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Karolinska Development correlated with the market. If Beta is less than 0 Karolinska Development generally moves in the opposite direction as compared to the market. If Karolinska Development Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Karolinska Development is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Karolinska Development is generally in the same direction as the market. If Beta > 1 Karolinska Development moves generally in the same direction as, but more than the movement of the benchmark.
Karolinska Development November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Karolinska Development help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Karolinska Development AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Karolinska Development AB based on widely used predictive technical indicators. In general, we focus on analyzing Karolinska Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Karolinska Development's daily price indicators and compare them against related drivers.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 18.09 | |||
| Value At Risk | (5.38) | |||
| Potential Upside | 4.92 |
Additional Tools for Karolinska Stock Analysis
When running Karolinska Development's price analysis, check to measure Karolinska Development's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karolinska Development is operating at the current time. Most of Karolinska Development's value examination focuses on studying past and present price action to predict the probability of Karolinska Development's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karolinska Development's price. Additionally, you may evaluate how the addition of Karolinska Development to your portfolios can decrease your overall portfolio volatility.